Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H7Cl3O |
Molecular Weight | 177.457 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)C(Cl)(Cl)Cl
InChI
InChIKey=OSASVXMJTNOKOY-UHFFFAOYSA-N
InChI=1S/C4H7Cl3O/c1-3(2,8)4(5,6)7/h8H,1-2H3
Molecular Formula | C4H7Cl3O |
Molecular Weight | 177.457 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Chlorobutanol, or trichloro-2-methyl-2-propanol, is an analgesic and sedative hypnotic in man, and an experimental general anesthetic. It has antibacterial and antifungal properties. It is also used chemical preservative for parenteral drugs. It was found, that chlorobutanol inhibited mammalian Nav 1.2 channels at concentrations less than those used to preserve parenteral solutions. Its mechanism of inhibiting Na channels differs from that of local anesthetics in that it does not show use dependent or state dependent inhibition.
Approval Year
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
10 day EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/7159691 |
600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROBUTANOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
43% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/7159691 |
600 mg single, oral dose: 600 mg route of administration: Oral experiment type: SINGLE co-administered: |
CHLOROBUTANOL plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
Doses
Dose | Population | Adverse events |
---|---|---|
600 mg single, oral Studied dose Dose: 600 mg Route: oral Route: single Dose: 600 mg Sources: Page: p.376 |
healthy, 20-30 n = 4 Health Status: healthy Age Group: 20-30 Sex: M Population Size: 4 Sources: Page: p.376 |
Other AEs: Sedation, Light headedness... Other AEs: Sedation Sources: Page: p.376Light headedness Euphoria |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Euphoria | 600 mg single, oral Studied dose Dose: 600 mg Route: oral Route: single Dose: 600 mg Sources: Page: p.376 |
healthy, 20-30 n = 4 Health Status: healthy Age Group: 20-30 Sex: M Population Size: 4 Sources: Page: p.376 |
|
Light headedness | 600 mg single, oral Studied dose Dose: 600 mg Route: oral Route: single Dose: 600 mg Sources: Page: p.376 |
healthy, 20-30 n = 4 Health Status: healthy Age Group: 20-30 Sex: M Population Size: 4 Sources: Page: p.376 |
|
Sedation | 600 mg single, oral Studied dose Dose: 600 mg Route: oral Route: single Dose: 600 mg Sources: Page: p.376 |
healthy, 20-30 n = 4 Health Status: healthy Age Group: 20-30 Sex: M Population Size: 4 Sources: Page: p.376 |
PubMed
Title | Date | PubMed |
---|---|---|
Is ketamine or its preservative responsible for neurotoxicity in the rabbit? | 1993 Jan |
|
Structural elucidation of disinfection by-products in treated drinking water. | 2001 |
|
Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. | 2001 Mar |
|
Ear drops for the removal of ear wax. | 2003 |
|
Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques. | 2003 |
|
Randomized clinical trial of docusate, triethanolamine polypeptide, and irrigation in cerumen removal in children. | 2003 Dec |
|
4-Chlorobutanol induces unusual reversible and irreversible thermal unfolding of ribonuclease A: thermodynamic, kinetic, and conformational characterization. | 2004 Apr |
|
Preventing exposure keratopathy in the critically ill: a prospective study comparing eye care regimes. | 2005 Aug |
|
An efficient synthesis of a dual PPAR alpha/gamma agonist and the formation of a sterically congested alpha-aryloxyisobutyric acid via a Bargellini reaction. | 2005 Oct 14 |
|
Cerumen removal products. | 2005 Sep-Oct |
|
Glucuronate, the precursor of vitamin C, is directly formed from UDP-glucuronate in liver. | 2006 Apr |
|
Are multidose over-the-counter artificial tears adequately preserved? | 2006 May |
|
Effect of ophthalmic solution components on acrylic intraocular lenses. | 2007 Jan |
|
Development and validation of a stability-indicating analytical method for the quantitation of oxytocin in pharmaceutical dosage forms. | 2007 Jan 4 |
|
Equimolar mixture of 2,2,2-trifluoroethanol and 4-chloro-1-butanol is a stronger inducer of molten globule state: isothermal titration calorimetric and spectroscopic studies. | 2007 Oct |
|
GC determination of acetone, acetaldehyde, ethanol, and methanol in biological matrices and cell culture. | 2009 Apr |
|
Reichardt's dye and its reactions with the alkylating agents 4-chloro-1-butanol, ethyl methanesulfonate, 1-bromobutane and Fast Red B - a potentially useful reagent for the detection of genotoxic impurities in pharmaceuticals. | 2009 Apr |
|
Methadone-associated Q-T interval prolongation and torsades de pointes. | 2009 May 1 |
|
Therapeutic approaches to cerebral vasospasm complicating ruptured aneurysm. | 2009 Nov 16 |
|
Allergy to ophthalmic preservatives. | 2009 Oct |
|
[Chlorobutanol poisoning: about a case]. | 2010 Oct |
|
Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines. | 2010 Sep 20 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7689400
It was examined chlorobutanol effect on on exocrine response and intracellular Ca2+ dynamics in isolated pancreatic acini of the rat. Chlorobutanol (1 mg ml-1) markedly inhibited the secretory response to cholecystokinin octapeptide (CCK-8), carbamylcholine chloride (carbachol), or sodium fluoride, a direct G-protein activator. However, chlorobutanol itself induced a maximal release of amylase when the dose was increased to 4 mg ml-1. Chlorobutanol inhibited 13 pM [125I]-CCK-8 or 0.5 nM [3H]-methylscopolamine chloride binding to the acinar cells in a dose-dependent manner. These results indicate that chlorobutanol produces discernible pharmacological effects on the secretory response in rat pancreatic acinar cells through changes in the Ca2+ dynamics.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:59:02 GMT 2023
by
admin
on
Fri Dec 15 15:59:02 GMT 2023
|
Record UNII |
HM4YQM8WRC
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
98896
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
||
|
WHO-ATC |
A04AD54
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
||
|
EPA PESTICIDE CODE |
17501
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
||
|
CFR |
21 CFR 310.538
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
||
|
WHO-VATC |
QA04AD54
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
||
|
WHO-VATC |
QA04AD04
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
||
|
WHO-ATC |
A04AD04
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
440
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
HM4YQM8WRC
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
100000081866
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
C45678
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
CONCEPT | Industrial Aid | ||
|
3092
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
C65317
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
44794
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
SUB11813MIG
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
CHEMBL1439973
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
2761
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
CHLOROBUTANOL
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odour, characteristic, camphoraceous.Solubility: Slightly soluble in water; very soluble in ethanol (~750 g/l) TS and ether R; soluble in glycerol R.Category: Antimicrobial preservative.Storage: Chlorobutanol should be kept in a tightly closed container. | ||
|
200-317-6
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
5977
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
DB11386
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
57-15-8
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
1112503
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
D002724
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
SUB06190MIG
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
DTXSID1041217
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
CHLOROBUTANOL
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | |||
|
m3399
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | Merck Index | ||
|
2378
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY | RxNorm | ||
|
HM4YQM8WRC
Created by
admin on Fri Dec 15 15:59:02 GMT 2023 , Edited by admin on Fri Dec 15 15:59:02 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SOLVATE->ANHYDROUS |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |